CYP 357 (Nasex-G 835 mg-25 mg)
Generic Name: guaifenesin/phenylephrine
Pill imprint CYP 357 has been identified as Nasex-G 835 mg-25 mg.
Nasex-G is used in the treatment of sinus symptoms; cough and nasal congestion and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Nasex-G 835 mg-25 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- CYP 357
- 835 mg-25 mg
- Elliptical / Oval
- Rx and/or OTC
- Drug Class:
- Upper respiratory combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Cypress Pharmaceutical Inc
More about Nasex-G (guaifenesin / phenylephrine)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Support Group
- 0 Reviews – Add your own review/rating
- Drug class: upper respiratory combinations
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.